GMP IPO Watch logo GMP IPO Watch
Equity Scheme - Flexi Cap Fund

Capitalmind Flexi Cap Fund

Direct Plan · Growth · Capitalmind Mutual Fund

Risk: Very High Risk
52W Low ₹9.47 23 Mar 2026 52W High ₹10.64 31 Aug 2026
₹10.1658 NAV as of 4 Nov 2026 +0.96% day change
Other Plans of This Fund
ISININF226401018
Scheme Code153738
StructureOpen Ended Schemes
Fund HouseCapitalmind Asset Management Private Limited
AUM (avg. July - September 2026)₹384 Cr
Expense Ratio (as of 3 Nov 2026)1.74%
Min. Investment₹5,000
Inception Date18 Jul 2025
BenchmarkNIFTY 500 TRI
NFO Period18 Jul 2025 – 28 Jul 2025

Returns

1Y +0.05%
Since Inception +2.15%

Annualised (CAGR) returns for periods over a year.

Want to invest in this fund?

Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.

Open Free Account

Rank in Category

PeriodThis FundCategory Avg.Rank
1W +1.86% +3.96% 45 of 46
1M +1.50% +2.78% 37 of 46
3M -1.44% -2.63% 11 of 44
6M +1.20% +3.55% 31 of 44
YTD -1.34% -0.88% 24 of 46
1Y +0.05% -1.20% 16 of 42
INCEPTION +2.15% — —

Ranked among: Equity Scheme - Flexi Cap Fund.

Rolling Returns

PeriodAverageBestWorstPositive PeriodsConsistency
3M +0.85% +8.22% -7.81% 64% 25%
6M +0.49% +10.66% -4.82% 48% 19%
1Y +3.21% +8.82% -5.80% 81% 33%

Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.

NAV History

AUM Trend (₹ Cr, quarterly average)

Expense Ratio Trend

Portfolio · Sep 2026

Asset Allocation

  • Equity96.02%
  • Debt0.07%
  • Cash3.91%
  • Other0.00%

Market Cap Split

  • Large Cap22.06%
  • Mid Cap39.15%
  • Small Cap34.81%
  • Others3.98%

Fundamentals

FundCategory
P/E28.2825.06
P/B4.563.71
Price / Sales4.703.16
Price / Cash Flow32.4520.06
Dividend Yield (%)0.681.13
Holdings31
Top 5 Stocks22.07%
Top 10 Stocks38.99%
Top 3 Sectors55.79%

Holdings · Sep 2026

HoldingSectorWeightChange (1M)
Welspun Corp Industrial Products 6.31% +0.93%
Laurus Labs Pharmaceuticals & Biotechnology 4.42% +0.82%
Clearing Corporation of India Ltd Net Current Assets 4.17% —
Divis Laboratories Pharmaceuticals & Biotechnology 3.90% +0.75%
Bank of Maharashtra Banks 3.79% -0.01%
Federal Bank Banks 3.65% -0.33%
RR Kabel Industrial Products 3.54% -0.45%
Torrent Pharmaceuticals Pharmaceuticals & Biotechnology 3.47% -0.08%
Karur Vysya Bank Banks 3.33% -0.12%
Karnataka Bank Banks 3.30% +0.04%
MCX Capital Markets 3.28% +0.95%
Anand Rathi Wealth Capital Markets 3.28% +0.59%
Radico Khaitan Beverages 3.21% +0.02%
Granules Pharmaceuticals & Biotechnology 3.20% +0.27%
Bajaj Auto Automobiles 3.18% +0.25%
View all 33 holdings
Samvardhana Motherson International Auto Components 3.16% —
RBL Bank Banks 3.07% —
Bosch Auto Components 3.06% —
Sona BLW Precision Forgings Auto Components 3.05% +0.16%
Titan Consumer Durables 3.03% -0.23%
Sai Life Sciences Pharmaceuticals & Biotechnology 3.02% —
PNB Housing Finance Finance 2.99% —
Aurobindo Pharma Pharmaceuticals & Biotechnology 2.95% +0.01%
Nykaa Retailing 2.89% -0.17%
Bharat Forge Auto Components 2.88% -0.17%
Apollo Hospitals Equity 2.81% +0.14%
Anthem Biosciences Pharmaceuticals & Biotechnology 2.78% —
Himadri Speciality Chemical Chemicals & Petrochemicals 2.77% +0.16%
Zydus Life Science Pharmaceuticals & Biotechnology 2.76% +0.09%
Grasim Industries Cement & Cement Products 2.51% -0.16%
Oracle Financial Services Software IT - Software 0.43% -2.69%
364T251226 Money Market 0.07% +0.00%
Net Receivables / (Payables) Net Current Assets -0.26% —

Sector Allocation · Sep 2026

View all 14 sectors
  • Healthcare Services 2.81%
  • Chemicals & Petrochemicals 2.77%
  • Cement & Cement Products 2.51%
  • IT - Software 0.43%

Risk Metrics

Standard Deviation

PeriodFundCategory
1Y 12.96 14.87 Low Volatility
What is this?

Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.

Sharpe Ratio

PeriodFundCategory
1Y -0.50 -0.53 Above Average
3Y -0.23 -0.37 Above Average
What is this?

Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).

Sortino Ratio

PeriodFundCategory
1Y 0.09 -0.02 Above Average
What is this?

Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.

Beta

PeriodFundCategory
1Y 0.64 0.96 Good Risk Adjusted Returns
What is this?

This value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market.

Compare With Peers

Scheme 1Y3Y5YSince Inception
ITI Flexi Cap Fund
Regular Plan · Growth Option
+9.40% +17.26% — +20.60%
Quant Flexi Cap Fund
Regular Plan · Growth Option
+7.24% +14.43% +12.87% +13.95%
BANK OF INDIA FLEXI CAP FUND
Direct Plan · Growth
+6.40% +18.73% +15.42% +25.10%
TRUSTMF Flexi Cap Fund
Regular Plan · Growth
+5.61% — — +8.31%
Taurus Flexi Cap Fund
Regular Plan · Growth
+5.61% +12.20% +9.69% +9.81%
360 ONE Flexicap Fund
Direct Plan · GROWTH Option
+5.51% +17.54% — +16.92%
UNIFI FLEXI CAP FUND
Regular Plan · GROWTH
+4.79% — — +4.64%
Navi Flexi Cap Fund
Regular Plan · Growth
+4.15% +9.99% +8.31% +11.34%
Bajaj Finserv Flexi Cap Fund
Direct Plan · Growth
+3.22% +16.59% — +15.98%
Axis Flexi Cap Fund
Direct Plan · Growth Option
+2.78% +14.32% +8.18% +13.48%

More From Capitalmind Asset Management Private Limited

Scheme 1Y3Y5YSince Inception
Capitalmind Arbitrage Fund
Direct Plan · Growth
— — — +6.14%
Capitalmind Multi Asset Allocation Fund
Direct Plan · Growth
— — — -5.52%
Capitalmind Liquid Fund
Direct Plan · Growth
— — — +6.49%

About This Scheme

Investment Objective

To generate long-term capital appreciation by investing predominantly in equity & equity related instruments across market capitalization i.e. large-cap, mid-cap and small-cap stocks. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.

Stated Asset Allocation

Equity & Equity related instruments of large cap, mid cap and small cap companies 65% to 100% Debt Securities & Money Market instruments (including Cash & cash equivalents) 0% to 35% Unitsissued by REITs and INVITs 0% to 10% Units of Mutual Fund Scheme 0% to 5%

Exit Load

For each purchase of Units through Lumpsum / switch-in / Systematic Investment Plan (SIP), Systematic Transfer Plan (STP), Exit load on redemption / Systematic Withdrawal Plan (SWP) / Switch-out, will be as follows: ? If Units redeemed or switched within 12 months from the date of allotment – 1% of the applicable NAV ? If redeemed/switched out after 12 months from the date of allotment – Nil ? If there is change in control of the AMC and/or change in the fundamental attributes of the Scheme and an investor wants to exit from the Scheme – Nil exit load.

Fund Managers

Mr. Anoop Vijaykumar Mr. Prateek Jain

Comanage Comanage

Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.

Market Closed · Opens 9:15 AM
NSE BSE NFO BFO CDS BCD MCX NSCOM